21 CFR Part 866 - IMMUNOLOGY AND MICROBIOLOGY DEVICES
- Subpart A - General Provisions (§§ 866.1 - 866.9)
- Subpart B - Diagnostic Devices (§§ 866.1620 - 866.1700)
- Subpart C - Microbiology Devices (§§ 866.2050 - 866.2900)
- Subpart D - Serological Reagents (§§ 866.3010 - 866.3990)
- Subpart E - Immunology Laboratory Equipment and Reagents (§§ 866.4070 - 866.4900)
- Subpart F - Immunological Test Systems (§§ 866.5040 - 866.5950)
- Subpart G - Tumor Associated Antigen immunological Test Systems (§§ 866.6010 - 866.6080)
Source:
47 FR 50823, Nov. 9, 1982, unless otherwise noted.
Editorial Note:
Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.
{'United States Code': [{'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '360', 'headtext': ' Registration of producers of drugs or devices', 'cleanpath': '/uscode/text/21/360'}, {'Title': '21', 'Section': '360c', 'headtext': ' Classification of devices intended for human use', 'cleanpath': '/uscode/text/21/360c'}, {'Title': '21', 'Section': '360e', 'headtext': ' Premarket approval', 'cleanpath': '/uscode/text/21/360e'}, {'Title': '21', 'Section': '360j', 'headtext': ' General provisions respecting control of devices intended for human use', 'cleanpath': '/uscode/text/21/360j'}, {'Title': '21', 'Section': '360l', 'headtext': ' Postmarket surveillance', 'cleanpath': '/uscode/text/21/360l'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}